Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli

• Published in: Biochemical journal Vol. 389; no. Pt 1; pp. 215 - 221
• Main Authors: Sparatore, Bianca, Patrone, Mauro, Passalacqua, Mario, Pedrazzi, Marco, Ledda, Sabina, Pontremoli, Sandro, Melloni, Edon
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd 01-07-2005
• Subjects: Calcium - metabolism; Calcium Signaling - drug effects; Cell Line, Tumor; Cell Movement - drug effects; Epidermal Growth Factor - pharmacology; HMGB1 Protein - antagonists & inhibitors; HMGB1 Protein - metabolism; HMGB1 Protein - pharmacology; Humans; Protein Binding
• ISSN: 0264-6021; 1470-8728
• DOI: 10.1042/bj20050053

HMGB1 (high-mobility group box 1) protein, a pleiotropic cytokine released by several cell types under physiological and pathological conditions, has been identified as a signal molecule active on A431 cells. Although extracellular HMGB1 itself does not trigger any detectable signalling effect on these cells, it induces an increased susceptibility to EGF (epidermal growth factor) stimulation. Specifically, at concentrations of EGF which promote undetectable or limited cell responses, the addition of sub-nanomolar concentrations of HMGB1 potentiates the effect of EGF by specifically activating a downstream pathway that leads to enhanced cell motility through an increase in Ca2+ influx, activation of extracellular-signal-regulated kinase 1/2 and remodelling of the actin cytoskeleton. These results, which identify extracellular HMGB1 as an activator of human tumour cell migration operating in concert with EGF, have important implications in the search for novel strategies to control tumour progression and metastatic invasion.